SOURCE: Axxess Pharma, Inc.

Axxess Pharma, Inc.

October 09, 2014 08:00 ET

Axxess Pharma to Expand TapouT Product Line Into 45 Nutritional Brick and Mortar US Retail Stores

Management Anticipates Full Expansion Into Over 500 Nutritional Brick and Mortar Retail Stores Within 3 to 4 Months

TORONTO, ON--(Marketwired - Oct 9, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that they have signed a contract with one of the leading health and wellness retailers in the United States. Under the agreement, some of Axxess Pharma's featured line of TapouT products will be available initially in 45 of their US brick and mortar retail stores within 30 days. Management anticipates their product line will be available in over 500 of their US brick and mortar retail stores within 3 to 4 months.

As part of the agreement, the large national health and wellness retailer will begin selling Axxess Pharma's TapouT Pain Relief Wipes. Currently, this highly effective, all-natural topical pain relief product is in high demand and is expected to be a top seller for the national retailer. Management is working to expand the product offerings and expects to have additional items featured by the national retail chain over the next few months.

Management anticipates continued strong revenue growth as the company expands their product reach into other leading national and global online and brick and mortar retail stores.

"We are honored to have our featured TapouT products on the shelves of one of the leading health and wellness companies in the United States. Our TapouT products have strong brand recognition," stated Dr. Bagi, President of Axxess Pharma, Inc. "We anticipate a full roll-out of our TapouT product line into more than 500 of their brick and mortar stores within 3-4 months."

"This is an exciting time for Axxess Pharma and their high demand TapouT line. We will continue to focus our efforts on rolling-out their TapouT line into other large, national and global retail stores," stated Mitch Gould, CEO of Nutritional Products International (NPI), a sales and brand management firm responsible for promoting the TapouT line.

About Axxess Pharma Inc.:

Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: http://buytapoutme.com and http://www.tapoutmusclerecovery.com.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

About TapouT:

TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com. For updates and more information, please visit TapouT.com. TapouT is a Trademark of ABG TapouT, LLC.

https://www.facebook.com/TapouT
https://twitter.com/TapouT
http://www.youtube.com/tapout

Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.

Contact Information